Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Represented Drugs Made In America Acquisition II in its initial public offering

Represented Drugs Made In America Acquisition II, a special purpose acquisition company planning to target companies in the pharmaceutical industry, in its $500 million initial public offering.